Well this is no secret but actually a business model, where if the population is healthy you are not seeing your doctor enough. So create a virus where misery is a business model. You can model a virus from other natural viruses. As noted above patent # US 7,220,852 B1- This patent actually protects the nucleic acid sequence of the SARS-CoV virus.
The claim? An isolated nucleic acid molecule consisting of the nucleotide sequence and from this SARS-CoV or SARS-CoV-1 is born!
The known groups of coronavirus are associated with a variety of diseases of humans and domestic animals (for example, cattle, pigs, cats, dogs, rodents, and birds), including gastroenteritis and upper and lower respiratory tract disease.
First Comes The Build
Coronavirus have not previously been known to cause severe disease in humans, but have been identified as a major cause of upper respiratory tract illness, including the common cold. Repeat infections in humans are common within and across stereotype, suggesting that immune response to coronavirus infection in humans is either incomplete or short lived. Coronavirus infection in animals can cause severe enteric or respiratory disease. Vaccination has been used successfully to prevent and control some coronavirus infections in animals. The ability of animal-specific coronaviruses to cause severe disease raises the possibility that coronavirus could also cause more severe disease in humans (Fields et al. eds. Fields Virology, 3rd edition, Raven Press, Philadelphia, 1323–1341, 1996; Mahey and Collier eds. Microbiology and Microbial Infections, Volume 1 Virology, 9th edition, Oxford University Press, 463–479, 1998).
Then Caution
In late 2002, cases of life-threatening respiratory disease with no identifiable etiology were reported from Guangdong Province, China, followed by reports from Vietnam, Canada, and Hong Kong of severe febrile respiratory illness that spread to household members and health care workers. The syndrome was designated “severe acute respiratory syndrome” (SARS) in February 2003 by the Centers for Disease Control and Prevention (MMWR, 52:241–48, 2003).
Off to the races: In 2003, when the SARS-CoV virus was discovered, several institutions were quick to unilaterally file patent applications for the total or partial sequence of the coronavirus genome.
Then Remedy to save Humanity
Past efforts to develop rapid diagnostics and vaccines for coronavirus infection in humans have been hampered by a lack of appropriate research models and the moderate course of disease in humans. Therefore, a need for rapid diagnostic tests and vaccines exists.
Just Business, A Star is Born
All the players are in the news and names on the patents with pallets of money in the game.
You actually want to take credit for this?
It just might come to this, much was lost around the world in life and monetary means. So if China wants fame, be careful what you wish for. Domestic Crime or an International Crime Against Humanity The whole world will get a piece of China, if they got the patent and/or copyrights for SARS-CoV-2 or did you get left holding the bag?
Vaccine step after patent applicant Sars-CoV-2:
In 2013, the Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program awarded grant funding to Moderna Therapeutics for the development of a new type of vaccine based on messenger RNA. The initial DARPA grant was W911NF-13-1-0417. The company used that technology to develop its COVID-19 vaccine, currently undergoing Phase I clinical trials in conjunction with NIH.29
M·CAM and Knowledge Ecology International have independently confirmed that Moderna has violated U.S. law in failing to disclose the U.S. government’s funding interest in their patents and patent applications. While this negligence impacts all of Moderna’s over 130 granted U.S. patents, it is particularly problematic for U.S. Patent 10,702,600 (‘600) which is the patent relating to, “a messenger ribonucleic acid (mRNA) comprising an open reading frame encoding a betacoronavirus (BetaCoV) S protein or S protein subunit formulated in a lipid nanoparticle.” The specific claims addressing the pivot to the SARS Coronavirus were patented on March 28, 2019 – 9 months before the SARS CoV-2
For Humanity, by Dr. Martin – Fauci – Dossier, pg 23, 24.
‘The Plandemic.’ LOL!
Msb1959 Blog 